Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus.
| Image |  |
|---|---|
| Description | scientific article published on 14 April 2010 |
| Author/s |
author: Brandon W. Higgs |
| Publication date | April 14, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |